Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma
Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC
One in 10 Continue Opioid Use Two Years After ICU Admission
Opioid use peaks in the first quarter after admission and declines continuously, but does not reach preadmission baseline over 24 months
Overall Pregnancy, Live Birth Outcomes Unchanged in Psoriasis
Of the births, 90.9 percent born full term, 9.1 percent born prematurely; few had neonatal problem or congenital anomaly
Zinc, Ascorbic Acid Do Not Cut Symptom Duration in SARS-CoV-2
No difference in length of time required to achieve 50 percent reduction in symptoms seen with supplements versus usual care
Factors Other Than Workplace Tied to COVID-19 Positivity in HCWs
Demographic, community factors show stronger influence than workplace exposure on COVID-19 risk in health care workers
Prolonged High-Dose Cyproterone Acetate Use Linked to Risk for Meningioma
Risk increased for meningiomas treated with surgery or radiotherapy; risk decreased after discontinuation of treatment
ICI Need Not Be Withheld in Those With Autoimmune Disease
Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID
AstraZeneca COVID-19 Vaccine Approved by the WHO
This is the second such approval from the WHO, which gave the Pfizer vaccine the green light in December
COVID-19 Vaccines Likely Available to All Americans by April: Fauci
By that time, increased supplies of the vaccines will allow most people to get vaccinated; herd immunity could be achieved by late summer
Prophylactic Anticoagulation May Cut COVID-19 Mortality
Lower 30-day mortality, no increase in serious bleeding events seen among COVID-19 inpatients receiving early prophylactic anticoagulation
